Eva Renee Barnett, M.B.A.

Eva Renee Barnett, M.B.A.

Former Chief Financial OfficeratImmunovant· In proxies 2022–2025

Pay in FY2025+19% from the year before · Immunovant stock -47.1% the same year

Eva Renee Barnett, M.B.A. was paid $4.0M in FY2025 (Mar), up 19%. Immunovant stock fell 47.1% that year.

Pay$100 in the stock at the end of FY21 → $38
Pay is from the Summary Compensation Table of each Immunovant proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmunovantPublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role +89%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?